Simpson Thacher represented McKesson Corporation in connection with a public offering of $2 billion aggregate principal amount of notes, consisting of $650 million aggregate principal amount of 4.650% Notes due 2030, $650 million aggregate principal amount of 4.950% Notes due 2032 and $700 million aggregate principal amount of 5.250% Notes due 2035. McKesson intends to use the net proceeds from the offering, together with cash on hand and/or commercial paper program borrowings, to fund its acquisition of a 70% controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC, an internal business and administrative services organization established by Florida Cancer Specialists & Research Institute, LLC.
McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. McKesson’s teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable.
The Simpson Thacher team included Edgar Lewandowski, Erica Yoon and Jacob Broz (Capital Markets); Katherine Reaves and Gordon Lee (Credit); Jonathan Cantor and Roberto Arza (Tax); Vanessa Burrows and Jacob Madden (Healthcare); Jeanne Annarumma (Executive Compensation and Employee Benefits); Michael Isby (Environmental); and Corina Holland (Intellectual Property).